The first two papers in this series (1, 2) described various marked metabolic derangements resulting from paralytic acute anterior poliomyelitis, particularly those involving nitrogen, creatine, calcium and phosphorus metabolism. The third paper (3) related the results of an attempt to minimize these extensive derangements by use of the slowly oscillating bed. The present paper reports results of an effort to modify the disordered metabolism of paralytic poliomyelitis by means of gonadal steroid hormones. These steroids have been shown in various clinical states to be effective in reducing the excretion of nitrogen, calcium and phosphorus and in favoring the positive balance of these elements. Because of these effects, it seemed reasonable to investigate whether or not gonadal steroids would act in a similar manner in a disease following which development of muscle and bone atrophy is prominent.
(Submitted for publication July 27, 1956; accepted November 26, 1956) The first two papers in this series (1, 2) described various marked metabolic derangements resulting from paralytic acute anterior poliomyelitis, particularly those involving nitrogen, creatine, calcium and phosphorus metabolism. The third paper (3) related the results of an attempt to minimize these extensive derangements by use of the slowly oscillating bed. The present paper reports results of an effort to modify the disordered metabolism of paralytic poliomyelitis by means of gonadal steroid hormones. These steroids have been shown in various clinical states to be effective in reducing the excretion of nitrogen, calcium and phosphorus and in favoring the positive balance of these elements. Because of these effects, it seemed reasonable to investigate whether or not gonadal steroids would act in a similar manner in a disease following which development of muscle and bone atrophy is prominent.
More specifically, the suggestion that gonadal steroids might have value in paralytic poliomyelitis arose from a variety of studies and observations. The protein anabolic effects of androgens have been summarized by Kochakian (4) . Papanicolaou and Falk (5) were evidently the first to show that testosterone administration would bring about hypertrophy of the general musculature, indicating that the retained protein was stored in muscle. The effects of androgens on calcium metabolism in post-menopausal and senile osteoporosis have been summarized by Albright and Reifenstein (6, 7) . They and others (8-11 ) have 1Aided by a grant from the National Foundation for Infantile Paralysis. 2Present address: National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland. t Died, January 6, 1956. shown the effectiveness of androgens in the osteoporosis of Cushing's syndrome. Presumably androgens act by increasing the amount of protein osteoid matrix, essential for bone formation. Estrogen administration has been shown to be useful in postmenopausal osteoporosis (12, 13), in the osteoporosis of acromegaly (14) and in osteoporosis associated with Paget's disease ( 15 ). Less effective than androgens in enhancing protein deposition, estrogens are thought to act by stimulating osteoblasts to lay down more protein matrix.
The effects of both types of gonadal hormones on the skeleton of animals have been extensively studied and summarized by Gardner and Pfeiffer (16). A study particularly related to the present one is that of Armstrong, Knowlton, and Gouze (17) in which disuse atrophy of the skeleton was brought about in mature rats by severing the brachial plexus; estradiol in modest doses was found generally to prevent the atrophy whereas testosterone did not, although only very large doses of the latter steroid were given.
PROCEDURE
The general plan, procedure, clinical care and diets employed in these studies were outlined in the first paper in this series (1) . The present report is based on the data of seven patients (D.A., J.C., R.W., F.S., C.R., J.W. and R.V.K.), all of whom were studied on the Metabolism Ward where closely controlled balance studies were carried out. J.W. and R.V.K. were females and the others males. Changes in diet, physical therapy or activity of the patients were in nearly all instances made not less than two weeks prior to and two to four weeks following a course of androgen or estrogen in order to provide suitable control periods before and after the administration of these hormonal agents. The relatively slow progress of physical improvement in these extensively paralyzed patients made this control possible.
G. DONALD WHEDON AND EPHRAIM SHORR
The hormonal preparations used were testosterone propionate, given intramuscularly in doses of 25 and 50 mgm. daily, and alpha-estradiol benzoate (Progynon-B), given intramuscularly in doses of 1.66 and 3.32 mgm. (10,000 and 20,000 rat units) daily. Testosterone propionate alone was given during various phases of the disease in eight studies for periods ranging from 12 to 42 days. Estradiol benzoate was given alone in two studies during the convalescent phase, for 18 and 30 days each. The two hormones were given concurrently (in separate syringes) in six studies for periods of 12 to 36 days. Four patients were given combined testosterone and estradiol at one time and testosterone alone at another so that in their data comparison was 1. combined administration of the hormones with those of androgen alone.
METHODS
The methods for analysis of urine, stool and serum for the various chemical constituents have been given in the first two papers of this series (1, 2) . Metabolic balance studies were carried out in six-day periods. The methods for measuring girth of thighs and calves and strength of muscle groups were given in the first paper (1) . Tests of basal metabolic rate were performed every 10 to 14 days by the method of Benedict and Roth (18). Measurements of skin temperature were made in two patients (F.S. and C.R.) by the method described in the third paper of this series (3).
Definitions and abbreviations. In this paper the various phases of illness are defined as follows: early convalescent, from the third to eighth week after onset of illness; convalescent, second through sixth month; and chronic, after the sixth month. The following abbreviations are employed: t.p. = testosterone propionate; e.b. = estradiol benzoate; and in Table III trogen excretion previously described ( 1 ) had passed its peak and was declining, and urinary creatine excretion was also beginning to recede from high levels. Urinary calcium excretion was approaching a peak, and, from the data of other patients who were not given gonadal steroids, would be expected to maintain a high plateau level for many weeks (2) . Testosterone propionate was given to two male patients, D.A. and R.W., beginning at the 27th and 28th days after onset of illness, respectively (Figures 1 and 2 
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known precursor of creatine, was determined in an effort to obtain information suggestive of changes in creatine synthesis (1) ; the excretion values of this substance were not significantly altered. Urinary creatinine continued to fall slowly, at a rate not evidently different from that of other patients not on the hormone. Body weight, previously declining rapidly, remained fairly stable during the 30-day testosterone administration interval, then fell again rather rapidly when the hormone was stopped.
Urinary calcium excretion showed a definite decrease on testosterone, falling from 0.392 gm. per day to 0.300 gm. per day in D.A. and from 0.648 gm. per day to 0.443 gm. per day in R.W.; fecal calcium was slightly diminished. Calcium balance became less negative by nearly 0.200 gm. per day in each patient. As was usually observed in these studies, the decrease in calcium excretion continued for two metabolic balance periods (twelve days) after the hormone was discontinued. Thereafter, increases in urinary calcium were sluggish and slight so that both urinary calcium and calcium balance tended to remain at a new level close to that reached at the conclusion of hormone administration. Phosphorus excretion changed closely with nitrogen. Urinary citric acid was measured because of its importance for the solubility of calcium (2, 19) ; in the case of D.A., citric acid varied little from the control level of 0.364 gm. per day, but in R.W. it fell from 0.381 gm. per day to an average of 0.209 gm. per day during t.p. Except for a fall of 0.5 mgm. per cent in serum phosphorus in R.W., no changes occurred in the serum chemistries. Urinary 17-ketosteroids increased from 9.1 to 28.0 mgm. per day in D.A. but only from 11.5 to 15.9 mgm. per day in R.W. The increase in dosage from 25 mgm. to 50 mgm. of t.p. daily in D.A. brought about no detectable modification in any of the changes in metabolic function described.
b. Convalescent phase. Testosterone propionate was given to two male patients, F.S. and C.R., five months after onset of their disease. Each was given 25 mgm. daily for 30 days, then 50 mgm. for the next 12 days (Figures 3 and 4) . In these two individuals in whom two-thirds or more of their original total muscle mass was without innervation, excretion of most metabolic constituents was fairly stable by this time; nitrogen was Stools were not collected for a three-day interval between metabolic periods 25 and 26; patient had an intercurrent aspiration pneumonitis (see case summary). Explanation of construction of chart is in legend for Figure  1 . As indicated, urinary creatine in this patient exceeded urinary creatinine.
virtually in balance, creatinuria was constant (approximately at 0.750 gm. per day for F.S. and 0.600 gm. per day for C.R.), urinary calcium excretion was at a steady high level (0.480 gm. per day for F.S. and 0.650 gm. per day for C.R.) and calcium balance was negative to the extent of approximately 0.500 gm. per day in each patient.
Testosterone propionate brought about a marked retention of nitrogen. When retention became maximal during the third week of hormone administration, daily positive nitrogen balance was 2.57 gm. for F.S. and 2.70 gm. for C.R.; the average daily storage throughout with respect to the control base-line (comparing the daily balances of control and experimental periods) was 1.68 and In the two patients, C.R. and J.W., given t.p. for only 12 days, similar changes were found: an increase in positivity of nitrogen balance, a decrease in urinary calcium and citric acid, and a decrease in negativity of calcium balance. In C.R. a slight decrease in creatinuria was noted whereas in J.W. the more usual finding in these studies was noted, an increase in creatinuria on t.p., then a further rise following.
In all of the testosterone studies urinary phosphorus and phosphorus balance moved with the changes in nitrogen and calcium. Measured phosphorus balances agreed closely with theoretical phosphorus balances calculated on the basis of the relationship of these two elements to phosphorus in muscle and bone (20 be considerably greater but would probably not be accurate because of the fact that the base-line was shifting. Rebound loss of nitrogen after cessation of the hormones was also difficult to calculate for the same reason; on the basis of absolute balance rebound loss was 61 per cent. In contrast to the other patients, J.C. showed a decrease in creatinuria on testosterone, from 0.655 gm. per day to 0.330; when estradiol was given, creatinuria increased again nearly to control levels. When the hormones were discontinued, creatinuria rebounded sharply to a level 0.300 gm. per day above control. Glycocyamine excretion began to increase on t.p., rose further on e.b. and t.p. combined and returned gradually to control levels 30 days after the two hormones were stopped; the control level was 0.122 gm. per day and the final peak on steroids 0.199 gm. per day. The effect of the hormones on urinary creatinine was apparently to bring about a temporary halt in the progressive fall to that point.
From examination of the decreases in urinary calcium excretion and negative calcium balance, it is difficult to determine whether estradiol added to the effect of testosterone; the total change in the 36-day interval was a fall of 0.195 gm. per day in urinary calcium and 0.215 gm. per day in the negative balance. Urinary citric acid excretion on t.p. increased in this patient from 0.636 gm. per day to 0.770, and continued to rise an additional 0.100 gm. per day when e.b. was added; citric acid did not rise further when steroid administration was interrupted. Serum phosphorus progressively decreased, the total decline being 0.6 mgm. per cent. Urinary 17-ketosteroids rose from 6.6 mgm. per day to 11.8 during the 18 days on t.p., then remained at the same level while e.b. was also given.
When androgen and estrogen were administered again in the same fashion beginning during the seventh month, the resultant changes differed principally in de-ree and were, in general, slightly less marked. N.trogen balance was already slightly positive, became more positive on t.p. to the extent of 1.57 gm. per day on the average, then nitrogen balance remained virtually the same with e.b. added. Total nitrogen storage with respect to the control balance was 60 gm., and the rebound loss afterward, 61 per cent; these figures are similar to those stated for the first course of the hormones in this patient but were calculated on a different basis. The pattern of change in creatinuria was similar to that during the first course of these steroids, the chief differences being that the levels rose to a greater extent when estrogen was added and during the rebound following. From a control level of 0.384 gm. per day, creatinuria dropped to a 0.279 gm. per day average during the third metabolic balance period, then rose to 0.529 gm. per day in the sixth; during the second period following, the level was 0.847 gm. per day. The changes after the third period on steroid were probably not due specifically to estrogen since a similar pattern of fall and then rise occurred in D.A. who was given e.b. with t.p. from the start. As in the first course of the two steroids in J.C., urinary glycocyamine was increased, from 0.174 gm. per day to 0.234. Urinary creatinine rose very slightly.
Decline In the study on F.S., peak nitrogen retention was + 3.35 gm. per day during the third six-day metabolic balance period; balance shifted from + 0.06 gm. per day during the preceding control balance periods to an average of + 2.49 over.the 36 days on the hormones. Total nitrogen storage was 89.6 gm.; the rebound loss over the following 24 days was 29 per cent of the amount stored on the hormones. Urinary creatine changed little over the first 12 days on steroids, then rose to a peak during the fourth period which was 0.247 gm. per day above the control level; after steroid administration creatinuria increased an additional 0.070 gm. per day. Urinary glycocyamine increased steadily from a control level of 0.126 gm. per day to a peak of 0.240 gm. per day during the fifth period; glycocyamine returned to the control level 21 days after androgen-estrogen had been stopped. Urinary creatinine showed some irregular elevations which were of doubtful significance.
Urinary calcium in F.S. decreased from 0.319 gm. per day to 0.203 gm. per day by the second period after hormone administration. Fecal calcium appeared to be slightly but definitely reduced, and the calcium balance shifted from -0.300 gm. per day to + 0.013. Urinary citric acid rose from 0.747 gm. per day to 0.900 gm. per day without an appreciable rise after the hormones were stopped. The usual decline in serum phosphorus was observed, amounting in this case to 0.7 mgm. per cent. Urinary 17-ketosteroids rose slightly on the steroids from 14.4 to 17.4 mgm. per day, but fell to 7.9 mgm. per day three weeks following.
Administration of the hormones to R.V.K. was brief, but it did afford an opportunity to observe initially the effect of estrogen followed by the addition of androgen. Nitrogen balance was unchanged by e.b. but shifted from + 1.55 gm. per day to an average of + 3.29 gm. per day when testosterone was added; administration of the hormones was so brief that total nitrogen storage and rebound loss were both extremely small. Creatinuria increased promptly and rose from 0.662 gm. per day to a peak of 1.029 gm. per day in the final combined period. After the hormone administration, creatinuria did not continue to rise but fell gradually over the next 24 days. The urine was not analyzed for glycocyamine. Table III summarizes the data with respect to effect of the steroids on sodium and potassium balances and on urinary chloride excretion. Behavior of these elements was somewhat variable from one patient to another, but from a review of the data of the group a general pattern emerged.
Sodium tended to be stored fairly promptly upon administration of the hormones, and in a few instances marked retention occurred during the first metabolic balance period, as indicated in the table. With regard to average sodium balance over the entire interval of steroid administration, however, a difference appeared in the effect on sodium between testosterone alone and when combined with estradiol, the combination causing sustained sodium retention while testosterone alone did not. This difference becomes evident if the testosterone data of D.A. and R.W. (I)8 are excluded. In these two studies t.p. was given relatively soon after onset of illness while hot packs were still being applied; the sodium excretion through the sweat, therefore, was undoubtedly considerable and variable so that sodium balance, in these two studies were inaccurate. In the re naining three studies of t.p. alone mean sodium balances on the hormone were virtually identical with the mean control sodium balances. Nevertheless, on cessation of t.p. all three patients had a sodium diuresis. tfiPost-control -First 12 days after steroid discontinued.
On combined steroids, however, sodium balance was distinctly more positive (by 0.312 gm. per day on the average) than during the control periods; on stopping the hormones, balance was less positive than during control in two of the three studies. On e.b. alone one patient, D.A., showed definite sodium retention whereas the other patient, R.W., showed virtually no change in sodium balance. Urinary chloride excretion was only slightly decreased (less than 4 per cent) during t.p. administration and slightly increased afterward. On combined hormone, however, the decrease in urinary chloride was more definite (9 per cent); again, there was a slight increase in chloride excretion following. On e.b. one patient showed a decrease similar in magnitude to that noted on combined steroid and one patient showed no change.
Crude water balances, based on fluid intake and output only, also showed a considerable degree of variation in certain patients. These data do not include calculations for the water of combustion of food or any estimates of changes in insensible water loss. Periodic determinations of the basal metabolic rate suggested that insensible water loss was probably increased during the early weeks. During this period water was probably also being lost in considerable amounts through the skin due to hot packs. These routes of probable additional water loss might account for the apparently large positive water balances during the control phases prior to t.p. administration in D.A. and R.W. (I). Review of data in the other studies indicated a consistent tendency to retain small amounts of fluid on t.p. and on combined steroid as compared with the control water balances and a variable tendency to return to the control balance level after hormone was stopped. In five studies the data suggested a water diuresis upon discontinuation of the steroids, the water balance during the first two balance periods following being more than 300 ml. per day less positive than during steroid administration; in two patients the balance became more positive during the first two periods following steroid. In the two estrogen studies crude water balances were less positive on the steroid and again less positive thereafter.
Potassium balances indicated that this element tended to be stored or lost as nitrogen was stored or lost. On testosterone alone and on combined t.p. and e.b., potassium balances were more positive than during control periods, and when the hormones were stopped, potassium balances were less positive coincident with the rebound loss of nitrogen. Exception was noted in both the early and late t.p. studies of R.W. in which potassium balance did not become more positive when nitro-gen storage was substantially increased. In explanation, the rare possibility is suggested of coincidental marked error in the true potassium intake during these phases, the potassium content of foods being notoriously variable; occurrence of this discrepancy, however, twice in the same patient and not in the other patients seems to call for a different interpretation, one which we are unable to offer. The potassium balance of R.V.K. on combined steroid was influenced by the fact that t.p. was given and nitrogen storage increased during the last two metabolic periods only so that the predominant influence was that of e.b. In the two studies of e.b. alone, potassium balances became less positive on the estrogen as did also the nitrogen balances.
In view of the report of Bower, Morgan, and Chaney (21) of excessive potassium excretion during the early weeks in a group of poliomyelitis patients, nearly all of whom needed a respirator, a brief account may be made of potassium excretion during the first few weeks in the four patients studied during that phase. Urinary potassium was observed to rise to a peak level of 3.3 to 5.5 gm. per day at the 11th to 13th day. At the level of potassium intakes given, negative potassium balances were maximally of the order of 2.0 gm. daily; negative potassium balance lasted until three to four weeks after onset. In comparison with the extensive losses of nitrogen (1), these potassium losses were modest, as judged by theoretical potassium balances calculated from the ratio of potassium to nitrogen in muscle (20); actual potassium losses were considerably less than the theoretical. Even if actual potassium losses had been high, however, they would not have evidenced particular loss of nerve tissue since nerve is not as rich in potassium as muscle (22).
II. Tests of Physiological Function
A. Basal metabolic rate
Determinations of basal metabolic rate were made approximately every 10 days to 2 weeks so that an average of 20 determinations was made during each patient's several months' study.
Among the seven patients studied from within the first two months after onset, five showed a gradual decrease in basal metabolism ( Review of tests performed during administration of testosterone propionate revealed no clear change in the studies of D.A. and R.W. (I) where the steroid was given beginning at approximately one month after onset. In F.S., C.R., and R.W. (II) later on, basal metabolism was raised by testosterone 5.4, 3.7 and 4.0 cal. per M.2 per hr., respectively, or by an average of 13 per cent (approximately equivalent to an increase of 11 percentage points in relation to Aub-DuBois standards); when the hormone was discontinued, basal metabolism fell again to control levels. In R.V.K. only single tests were made before and during testosterone administration.
On combined testosterone and estrogen basal metabolism of D.A. and F.S. increased 2.7 and 4.9 cal. per M.2 per hr. or 8 and 15 per cent, respectively. In R.W. and R.V.K. too few tests were carried out. In both administrations of steroid to J.C., tests showed modest variations and no clear trend. On estrogen alone, tests in D.A. indicated a 13 per cent rise, whereas during the short period that estrogen was given to R.W. only one test was performed.
B. Muscle strength
The pattern of gradually increasing muscle strength from the second week for five or more months was described in the first paper of this series. Ergometer tests made at intervals of every one to two weeks showed increases during steroid administration in several patients, but in none did the tests suggest that these increases might be due to hormonal influence rather than just part of the natural course of improvement.
C. Leg girth
During the first two to five months leg girth, measured every four to eight days, gradually decreased as involved leg muscles underwent varying degrees of atrophy (1) . Hormonal administration during these first several months did not prevent nor alter the rate of this process.
When testosterone propionate was given five months or more after onset to four patients, a mean increase in calf circumference resulted amounting to 1.0 cm. (approximately 3 per cent) and in thigh girth 1.2 cm. (also approximately 3 per cent); a decrease of similar proportions occured over the first two weeks after the hormone was discontinued. Similar increases occurred with combined steroid, the average increase in calf circumference being 0.7 cm. and in the thighs 1.0 cm. Although electrolyte and water changes on testosterone and combined t.p. and e.b. were not marked, it is not possible to be at all certain that the increases in leg girth occurring on these steroids reflected increases in muscle mass.
On estrogen alone, D.A. showed no change in girth and R.W. an increase of only 0.4 cm. in both calves and thighs, an insignificant amount.
D. Skin temperature
Measurements of skin temperature with the Hardy radiometer were made in two patients. In F.S. combined t.p. and e.b. brought about a rise in the temperature of the feet of 1.80 C. and of the legs of 0.60 C., accompanied by no significant change in total average skin temperature over the whole body. Testosterone alone in this patient and in C.R. resulted in no consistent changes in skin temperature in any area.
E. Clinical effects
Experience with use of gonadal hormones in these studies was reviewed for possible additions to our information regarding their clinical masculinizing or feminizing effects. Predominant findings were evidence of individual variation among patients and of neutralization of the side effects of one hormone by the high dosage of another hormone, which then exerted its own effects.
Among the male patients, predominant in this group, five were given testosterone propionate alone. One patient noted an increased frequency of erections and transiently developed acne with 400 to 450 mgm. and another acne after 600 mgm. The latter patient when given testosterone a second time noted some difficulty starting his urinary stream after approximately 450 mgm. but did not develop acne by the time the steroid was stopped after a total dose of 600 mgm. A third patient (F.S.) reported increased beard growth and an increase in sexual interest and erections when he had received 750 to 900 mgm. The other two patients were given 1050 and 1350 mgm. total without clinical effects.
The two male patients given estradiol alone both developed areolar tenderness and palpable tissue beneath the areolae; R.W. did so after 30 mgm. of estradiol benzoate and D.A. after 50 to 60 mgm. (180,000 and 300,000 to 360,000 rat units, respectively).
Combined androgen and estrogen were given to males on five occasions, in each instance at a ratio of 15 mgm. t.p. to 1 mgm. of e.b. R.W. noted areolar tenderness after 30 mgm. of estradiol (180,000 rat units), the same accumulated dosage at which this symptom was noted in this patient when e.b. was given alone. F.S. also noted areolar tenderness at this dosage, but the discomfort subsided as the hormones were continued; this patient had noted "masculinizing" symptoms at 750 to 900 mgm. of t.p. alone but on combined steroids noted no such effects by the time steroids were discontinued after 900 mgm. of t.p. had been given. J.C., given combined steroids twice, had areolar area tenderness after 15 mgm. of e.b. during one course and after approximately 25 mgm. during the other (90,000 and 150,000 rat units, respectively). D.A. had no feminizing discomfort after a total of 50 mgm. of e.b. with 600 mgm. of t.p. even though during the final metabolic balance period the androgen: estrogen ratio was only 7.5: 1.
R.V.K., a female, developed huskiness of the voice and facial acne after 650 mgm. of testosterone propionate when given alone and after 600 mgm. when given with estradiol benzoate. The ratio of the combined steroids given this patient was 30: 1 by weight, testosterone propionate to estradiol benzoate.
G. DONALD WHEDON AND EPHRAIM SHORR COMMENT
The studies reported in this paper have indicated a number of metabolic and physiological effects of gonadal steroids in adult patients with paralytic poliomyelitis. The effects in general were similar to those previously reported in other conditions, but certain exceptions were noted.
Effects on calcium metabolism
Among the metabolic effects, probably the most important was the action of testosterone propionate and combined t.p. and estradiol benzoate in decreasing calcium excretion (7, 23) . Onset of this action was slow, requiring as long as one to two weeks. Then, for the length of time the hormones were given in these studies (up to 42 days), the change was gradually progressive and tended to extend for up to 12 days after the hormones had been discontinued. Thereafter, urinary calcium excretion and balance generally returned sluggishly toward preceding levels. In a few instances, frequently during later months of the convalescent phase or during the chronic phase, calcium excretion remained more or less at the final level reached just following hormone administration. The pattern of action suggested that these hormones would produce an even greater total effect if given continuously or in repeated long courses rather than in the relatively brief investigative trials employed in these studies.
Reductive action on calcium excretion was shown by all three forms of hormone administration, androgen, estrogen and the combination of the two, but not consistently in the case of estrogen. The two estrogen studies were each of unusual interest, one because in it calcium storage occurred coincident with an increase in nitrogen excretion, the other because urinary calcium increased so that no net calcium storage resulted.
A number of previous studies have shown the efficacy of these hormones in conditions in which demineralization is already established, such as postmenopausal and senile osteoporosis (6, 12, 13), Cushing's syndrome (8-11) and acromegaly (14) . The present studies suggest their possible usefulness either in the prevention of or in the reduction of the severity of mineral loss as it is occurring, in this and in other paralytic disorders or in other states in which immobilization plays a prominent part. Another potential benefit lies in the fact that the reduction in urinary calcium would lessen the likelihood of calculus formation; the accompanying reduction in urinary phosphorus would be additionally helpful. If these quantitative effects were combined with close attention to adequate urine volumes and if hormone combinations were given which would maintain satisfactory levels of urinary citric acid (see below), a decrease in incidence of urinary tract stone formation in immobilizing states seems reasonable to be expected.
Nitrogen sparing action
The nitrogen or protein sparing action of testosterone, alone or in combination with estrogen, was clearly demonstrated during the convalescent and chronic phases in these studies, as it has been consistently in many other observations (4, 10, 23-26). A question of interest is whether the data gave any indication of the location of the deposited protein.
Comparison of the concomitant changes in excretion of phosphorus and sulphur indicated that nitrogen was being stored with these elements in the proportion in which they are found in muscle tissue. The measured phosphorus balances were always within 5 per cent (as related to the intake level) of theoretical phosphorus balances calculated from the balances of nitrogen and calcium, anticipating that phosphorus would be excreted or stored with these elements in the proportion found in muscle and bone (20) . Calculation of the ratios of urinary nitrogen to urinary sulphur, balance period by balance period, revealed them to lie generally within the usual or normal range of 14:1 to 16:1 (1), but occasionally values as high as 17.5: 1 were obtained. A frequent tendency toward higher ratios appeared during administration of testosterone and immediately following, suggesting the possibility at those times of more tenacious storage of sulphur-rich compounds.
The nitrogen-phosphorus-sulphur relationships indicated that protein was likely being stored in tissues having the composition of muscle, but no way was evident of determining whether there might be any predilection of the stored protein for denervated muscle, intact muscle or other tissues of similar composition. Reassurance that the pro-tein was being stored mainly in muscle rather than in other tissues is afforded by the finding of Kochakian, Robertson, and Bartlett (27) Creatine synthesis and storage Testosterone propionate and methyl testosterone are generally regarded as having dissimilar effects on creatine metabolism. The 17-methyl compound causes an excess creatinuria and is believed to stimulate creatine synthesis and enhance creatine storage; the propionate is thought to favor only the storage of creatine (32). Kochakian (4) has stated that the effects of the two compounds may be alike and that there is only an apparent dissimilarity due to the likelihood that the 17-methyl group hastens these effects. Keutmann, Bassett, and Kochakian (33) measured the creatinuria after cessation of testosterone propionate in a patient with Cushing's syndrome, found it greater than the amount retained during administration of the hormone and concluded that the propionate increases both synthesis and storage of creatine. Our studies support this latter view. In one patient with more unaffected total muscle mass than the others, a decrease in creatinuria occurred indicative of increased storage. In the other patients, however, creatinuria gradually increased, suggestive of increased synthesis. In two instances (D.A. and R.W. [II] ) the increase in creatinuria on testosterone was followed by a sharp additional increase reminiscent of the rebound rise seen in patients with normal muscle metabolism immediately following testosterone propionate; in these two instances evidence is visible of both increased synthesis and storage.
These various patterns may all be reconciled by the hypothesis that both synthesis and storage are aided by this steroid.
The indication that synthesis is increased by testosterone propionate is supported by the glycocyamine data. Urinary excretion of this substance was measured in three testosterone studies. In the second study of R.W. and in the two studies of J.C., the latter having been given testosterone alone for 18 days prior to combined steroid, substantial increases in urinary glycocyamine excretion occurred. The increased excretion of this known creatine precursor suggests that production of the glycine-amidine part of the creatine molecule had been increased in liver and kidney.
A different situation was apparently present with regard to the influence of testosterone on creatine synthesis during the first two months after onset, as indicated by absence of change of glycocyamine excretion in the two patients given testosterone during this early phase. This lack of response in glycocyamine occurred at a time when urinary creatine levels were still high so that the possibility comes to mind that an increase in creatine production by hormone may have been suppressed by the already copious amounts available and circulating. This situation may be similar to that noted in a study in progressive muscular dystrophy (34, 35) in which testosterone propionate failed to produce an increase in urinary glycocyamine; an increase in creatine storage occurred in these dystrophy patients since a rise in creatinuria resulted after the hormone was stopped.
In the two studies in which estradiol was given, a distinct increase was noted in creatinuria and in urinary glycocyamine indicative of a stimulation of creatine synthesis by this hormone. Since creatinuria began to fall within a few days after estradiol was stopped and since, in any event, there was no rebound rise in creatinuria similar to that following testosterone, it seems probable that little or no increase in creatine storage occurred under the influence of this estrogen. Increased urinary creatine excretion by an estrogen has been barely noted in previous studies. Knowlton, Kenyon, Sandiford, Lotwin, and Fricker (30) described an increase in creatinuria from 0.200 to 0.400 gm. per day on 5 mgm. of estradiol in a girl with adrenogenital syndrome but not on administration to a normal woman. From the charted data of Case 10 in the study of Williams, Whittenberger, Bissell, and Weinglass (36) of Addison's disease, there appeared to -be a slight increase in creatinuria on 5 mgm. of stilbestrol given for six days. Because of the plan of the study of Deakins, Friedgood, and Ferrebee (37) of a patient with Cushing's syndrome, it was difficult to determine whether creatinuria had been influenced by stilbestrol. We have been unable to find measurements of urinary glycocyamine in previous studies of the effects of estrogens.
Increases in urinary creatinine in a number of instances during the course of testosterone and combined steroid administration reflected the suggested enhancement of creatine synthesis and storage. These increases in creatinine, however, occurred in only approximately one-half of the studies and quantitatively were usually small.
Changes in electrolyte excretion
Because of similarities in structure between the gonadal steroids and adreno-cortical hormones, Thorn and Harrop (38) suspected that androgenic and estrogenic preparations might have salt and water retaining properties. In normal male dogs they demonstrated (38, 39) reduction in urinary volume, sodium and chloride and a slight increase in urinary potassium by single injections of these steroids, estradiol and progesterone having the greatest sodium retaining effect and testosterone the least. In addition, estrone, alpha-estradiol and testosterone caused a decrease in urinary phosphate and nitrogen; testosterone propionate (25 mgm. daily) given to a normal male subject brought about a reduction in urinary potassium as well as in sodium, chloride, phosphorus and nitrogen (39). Thorn, Nelson, and Thorn (40) extended observations in dogs of the effect of ovarian hormones and testosterone on salt and water retention and investigated human pre-menstrual weight gain, finding it associated with sodium, chloride and water retention and the increased urinary excretion of "estrogenic substance."
The present study confirms Thorn's opinion that testosterone is a relatively weak sodium retainer in that sodium balances over several metabolic balance periods on this steroid averaged the same as the control balances; two of three patients, however, showed distinct sodium retention during the first six days on testosterone and all showed sodium diuresis when it was withdrawn. Variation from patient to patient was emphasized by the marked sodium retention by one patient on estradiol benzoate and virtually none by the other patient. When the two steroids were given together, definite sodium retention consistently occurred, but here again individual variation was evident.
Urinary chloride excretion data were less variable than the sodium data, urinary chloride being diminished slightly in all three forms of hormone administration; no change occurred in one of the estradiol studies. Chloride diuresis after the hormones were discontinued occurred in five studies and did not in three.
The water balance data were consistent with respect to the effects of testosterone and combined steroid in that all studies with these two forms of hormone showed more positive water balances on steroid, by an average of a little more than 100 ml. daily. This is more than twice the amount of fluid storage associated with new protoplasm which would be anticipated (20) from the average nitrogen storage when testosterone or combined steroid were given (2.47 gm. N per day). Subsequent water diuresis occurred less consistently, although in five studies the water balance over the first twelve days after steroid was discontinued averaged more than 300 ml. per day less positive than during steroid administration.
Water balance data on the two patients on estradiol, however, recall the conflicting results obtained in various studies since those of Thorn. Knowlton and her co-workers (30) noted a decrease in urine volume on estradiol in one experiment and later noted no change in a second experiment on the same patient. Shapiro (41), who gave 7.5 mgm. of estradiol benzoate daily for five days to patients with secondary amenorrhea and to patients with diabetes insipidus, consistently obtained a decrease in urine volume followed by an increase when estradiol was stopped. On the other hand, Sharpey-Schafer and Schrire (42), who gave estradiol benzoate in approximately the same dosage as Shapiro for 7 to 10 days to 14 women, before and after the menopause, reported no decrease in urine volume. In our two males the latter result was largely obtained with perhaps a slight loss of water on estradiol and a further loss following. No evidence was found in our data for a transient storage of water during the first few days on estrogen as reported recently by Preedy and Aitken (43) using a larger dose.
Potassium balances became more positive on testosterone and combined steroid in association with nitrogen storage. On estradiol, potassium balances became less positive as did also the nitrogen balances. Although it is possible that these gonadal steroids may have a desoxycorticosteronelike action on the kidney, as has been suggested (39), apparently this action is obscured if the hormones provide sufficient stimulus to tissue growth and nitrogen storage, requiring the accompanying deposition of potassium. This would explain in the present studies the differences in effect on potassium balances between testosterone and estradiol.
Effects on urinary 17-ketosteroid excretion
The increases in urinary 17-ketosteroids on testosterone propionate in the present studies were in accord with previous experience (44). Reports of the effects of estrogens on 17-ketosteroids are apparently meagre. Hamblen, Pattee, and Cuyler (45) in 22 women with various types of ovarian insufficiency noted elevated "androgenic titers" and with estradiol lowered them to normal, the reductions ranging from 14 to 30 per cent. Salter, Hum, and Oesterling (46) in a female pseudohermaphrodite brought about a marked decrease (approximately 80 per cent) with 10 mgm. daily of stilbestrol. In our two male patients given estradiol benzoate the 17-ketosteroids were lowered by 22 per cent and 34 per cent, in the general range of reduction noted by Hamblen, Pattee, and Cuyler. Presumably the decreased excretion results from partial suppression of anterior pituitary production of gonadotrophin or ACTH or both.
Effects on urinary citric acid excretion Opposing effects of androgen and estrogen were seen consistently on urinary citric acid excretion, androgen decreasing and estrogen increasing. When the steroids were combined, the usual result was a neutralization so that citric acid varied little from the control level. When the combined 1013 steroids were stopped, frequently a rise in urinary citric acid appeared, suggesting a prolongation of the estrogen effect on this constituent.
The action of estrogen to increase urinary citric acid is an import-ant one for the problem of urinary tract stone formation, particularly where large amounts of calcium are being excreted. Abundant amounts of citric acid in the urine are useful for assistance in keeping calcium in solution (19, 47). Thus, although testosterone alone supplies many of the principal, desired metabolic effects which would assist in the management of the clinical problem of paralysis, the addition of estrogen serves a particularly useful purpose in counteracting the lowering effect of androgen on urinary citric acid.
Testosterone was also shown to cause a small but consistent increase of 0. (4, 24, 48 ). The few series in which an increase was not noted upon administration of this steroid were apparently those in which it was given for less than 10 days or in doses of less than 25 mgm. daily.
Clinical or side effects
In addition to their metabolic effects, gonadal hormones have various clinical effects (49-51) related mainly to their responsibility in natural production for the maleness or femaleness of the individual. Although certain undesirable side-effects may occur when a hormone is given to a patient of the same gender, by far the more disturbing effects are related to the production of symptoms or signs generally attributed to the opposite sex. These sex-related effects have been responsible for reluctance on the part of many physicians to use these hormones widely. It has not been clear whether some of these side-effects might be overcome by use of combinations of male and female hormones or only by restriction of daily or total dosage to certain limits, the latter course possibly leading at least in part to loss of useful action.
Review of the clinical or side effects from the administration of gonadal steroids in this series revealed mainly considerable variation from patient to patient in the accumulated dosage level at which these effects became evident. On testosterone, for example, two male patients developed acne after 400 and 600 mgm., respectively, and two others no noticeable effects after 1050 and 1350 mgm. The small experience in this predominantly male group of patients tended to support the idea that a 20: 1 weight ratio of testosterone propionate to estradiol benzoate is neutralizing with respect to clinical effects (52); a 15: 1 ratio was usually slightly feminizing and 30: 1 in the one instance given was masculinizing. This tentative conclusion should not be projected to effects to be anticipated either on longer administration of steroids or in predominantly female groups of patients. In the few instances in which it was possible to observe the situation, a dosage of a hormone, which produced side-effects when given alone, did not if given again with the hormone of the opposite sex, the latter being in preponderant dosage; in these second circumstances the now preponderant hormone exerted its own clinical effects.
Comparison of effects of testosterone propionate alone and combined with estradiol benzoate An evaluation of whether estrogen in combination with androgen exerted greater effects than androgen alone was possible in three patients and to a limited extent in a fourth. Most observations indicated no clear advantage of combined steroid administration. Nitrogen storage was slightly greater on androgen alone in two patients and slightly more on combined steroids in one, but the significant difference with respect to nitrogen was that the rebound loss after discontinuation of hormone was considerably greater with combined steroid administration; after testosterone alone the rebound loss of nitrogen averaged only 8 per cent of the total stored on the steroid. Creatinuria was increased more by combined steroid in two patients and by testosterone alone in one; in the latter patient, glycocyamine excretion was measured under both forms of hormone administration and was found to be more increased by combined steroid. A lack of consistent pattern was also present with respect to the minor changes in urinary creatinine. Decreases in serum phosphorus and increases in urinary 17-ketosteroids were virtually the same on either form of steroid.
In calcium and citric acid metabolism, however, advantages were indicated for giving estrogen and androgen together over androgen alone, although not in every case. Allowing for the fact that more marked changes were possible during the early months when excretion of calcium was at high level, the urinary calcium of two patients, D.A. and R.W., was more greatly lowered (and over a shorter period) by combined steroid than by testosterone alone, particularly percentagewise. In F.S., the percentage reduction was equal by the two forms although the decrease was quantitatively greater by testosterone, given earlier than the combined. In contrast to these effects, estradiol benzoate given alone caused an increase in urinary calcium in two of the three instances in which it was given. Negative calcium balance was considerably more greatly reduced by combined steroid than by t.p. in one patient, R.W. In D.A., the reduction of negative balance was approximately the same by the two forms, although it may be pointed out that testosterone alone was given for six days longer. The data of F.S. were preliminarily reported (53) to show a greater reduction by combined steroid to the extent of 85 mgm. per day; this figure is correct if one compares only the control balance with the last metabolic balance period on steroid. If one takes into account, however, the frequent continuation of effect after hormone is stopped, which in this patient led to a continuing reduction in calcium excretion over the next 12 days after testosterone was discontinued, then the change in calcium balance in this patient was approximately equal by both forms of steroids. The studies of R.V.K. are difficult to compare with respect to calcium metabolism because of their short duration and the preponderant total dosage of estradiol when combined steroid was given. In the studies of J.C. in which combined steroid was given preceded by 18 days on testosterone alone, no obvious effect was noted in nitrogen, phosphorus or calcium metabolism from the addition of the estrogen to testosterone.
This lack of uniform advantage of combined steroid over testosterone alone was pointed out in a recent review (53) of twelve cases in the literature in which the effects of the two forms of steroid administration on calcium balance could be compared. In four of the twelve cases no difference was detectable, while in eight an additive effect of estrogen was present, usually equal to approximately 100 mgm. of calcium per day. Despite this lack of uniformity, the number of instances of added benefit to calcium storage (or reduced loss) from combined steroids was in the majority. Consideration should also be given to the added advantage of combined steroids for providing levels of urinary citric acid more protective of calcium solubility than those produced by testosterone alone. For these reasons, in clinical situations in which urinary tract stone formation and large losses of calcium from the skeleton are serious threats, it seems preferable to advise combined administration of testosterone and estrogen.
Application to treatment of disease
These studies were originally inititated for the purpose of increasing knowledge of the natural processes of paralytic acute anterior poliomyelitis and of possibly indicating improved methods of management. Fortunately, the evident promise of poliomyelitis vaccine makes these findings less widely applicable to infantile paralysis. Nevertheless, a number of features which have been described in these papers are presumably common, in varying degree, to other conditions, such as paraplegia or extensive injury, and the hormonal effects observed should have useful application to these disorders. 4. Urinary citric acid excretion was reduced by testosterone propionate in all but one patient and increased by estradiol benzoate. When the two steroids were given together, urinary citric acid varied little from control levels. The significance of these effects for urinary calcium solubility was pointed out. 5 . Serum phosphorus was reduced slightly by testosterone and by combined steroids and unchanged by estradiol; no other significant serum chemistry changes were noted.
6. Sodium tended to be stored transiently under the influence of testosterone, but mean sodium balances over the entire course of testosterone administration were virtually identical with control sodium balances; sodium diuresis occurred, however, when testosterone was discontinued. On combined steroids definite and continuing sodium retention occurred. On estradiol, sodium retention occurred in one patient and not in another. Urinary chloride excretion diminished slightly during all three forms of hormone administration.
7. Water retention averaging slightly more than 100 ml. per day occurred on testosterone alone and on combined steroids; in five studies, water balances during the first 12 days following discontinuation of these steroids were more than 300 ml. per day less positive than during steroid administration. Water retention did not occur on estradiol benzoate alone in the two males to whom this steroid was given.
8. Potassium was retained on testosterone alone and on combined steroids. Potassium balances became less positive on estradiol benzoate. 9. Observations with respect to physiological functions were as follows: Increase in basal metabolic rate on all three forms of steroid administration was 8 to 15 per cent. Gradual improvement in muscle strength during the convalescent phase did not appear to be influenced by hormone administration. Small increases in calf and thigh girth occurred on testosterone and combined steroids. Combined steroids brought about a rise in skin temperature of the feet and legs in the one patient in which this study was made; testosterone alone caused no rise in skin temperature in the two patients so observed.
10. Tables I-IX. Tables X-XVIII. $ N balances days 3 to 32 based on assumed daily fecal N value of 1.00 gm., the average analyzed fecal N loss during periods I through IV. Standing with braces * Seven-day periods. (Table I) .
Hot pack therapy for 3 hours daily was begun on the 5th day after onset and continued for two and one-half months. Muscle re-education was begun on 19th day with the patient in bed, and from 54th day this therapy was given in the pool. From 79th day physical therapy was given in the gymnasium as well as in the pool. Increase in appetite required elevation of dietary intake on 57th day from 2020 calories to 2400, the protein and calcium intake remaining unchanged.
The patient began sitting in a chair on 69th day, began standing on 78th day, walking with "walker" on 99th day, with crutches on 105th day and with the aid of only a cane on 153rd day. Muscle examination at 6 months after onset is given in Appendix A, Table XIX. The patient was discharged on 180th day and thereafter received physical therapy as an out-patient until readmission from 282nd to 298th days for further metabolic observations. The patient returned to medical school, completed his course and is now carrying out residency duties with occasional use of cane.
2. M.O'M., 21-year-old female secretary (NYH No. 553257); onset of illness Oct. 6, 1949, with sore throat, headache, nausea, vomiting, fever, and history of left chronic otitis media; admitted to New York Hospital (Infectious Disease Ward) Oct. 7. Physical examination showed temperature of 39.5°C., perforated left ear drum draining purulent material, slight pharyngeal injection and moderate stiffness of neck. Spinal fluid contained 330 white cells per mm.', 60 per cent lymphocytes. Onset of paralysis Oct. 9, third day after onset, with weakness of left deltoid, and following day weakness of intercostals and lower extremities. V.C. on 5th day was 1250 ml. Nasal oxygen given 5th and 6th days. Temperature reached normal on 6th day and remained normal thereafter, except for minimal elevation 13th to 15th days, reason not evident. Muscle examination at maximal weakness is given in Appendix A, Table XIX. The patient was transferred to the Metabolism Ward on Oct. 19, 13th day after onset. The patient was able to take a constant dietary intake beginning on the 25th day (Table I) .
Special procedures: M.O'M. was placed on a Sanders oscillating bed on the 8th day after onset. The bed oscillated 12 to 15 (average 14) hours daily through a total arc of 21 degrees (2 head down to 19 feet down). Oscillating time each day could not be extended because oscillation was too uncomfortable with patient on her side, due to tightness and pain in the shoulders; patient was able to sleep with bed oscillating when lying on back. Oscillation was discontinued on the 40th day after onset after a total period of 33 days.
Standard therapy and course: Hot pack therapy for 2 hours daily was begun on the 3rd day, was supplemented with hot tub 20 minutes daily beginning on the 6th day; packs were continued for two and one-half months. Passive motion was begun on the 5th day. Muscle re-education was started on the 14th day in bed, from 71st day was given in the pool and from 92nd day in gymnasium as well as pool.
Ventilatory function remained stationary until the 20th day, then steadily improved, V.C. on the 29th day being 1830 ml., on the 86th day 2075 ml. The patient began sitting in chair on 89th day, began standing 92nd day, walking with "walker" 101st day, with crutches 125th day, with one crutch 149th day and with one cane 167th day. Muscle examination 6 months after onset (time of discharge) is given in Appendix A, Standard therapy and course: Hot pack therapy 4 to 6 hours daily was begun on the 7th day after onset and continued for two and one-half months. Muscle re-education was begun on the 18th day in bed, from the 75th day was given in the pool and from 81st day in gymnasium as well as pool. The patient also began sitting in chair on 81st day, began standing and walking in pool on 90th day. On 147th day dietary intake was reduced from 2800 calories to 2000 calories, nitrogen and calcium remaining the same, for the purpose of halting patient's perceptible increase in fat deposition. The patient began standing and walking a few steps with "walker" on 165th day, with crutches and long leg brace on 183rd day. Muscle examination at 6 months is given in Appendix A, Table  XIX . At time of discharge (262nd day) patient was beginning to take few steps with crutches and without brace.
At present patient walks with two canes and short dropfoot brace on right foot, works as a building contractor. (Table I) .
Special procedure: J.C. was placed on a Sanders oscillating bed on the 14th day after onset. The bed was set to rock through an arc of 21 degrees (1 degree head down and 20 feet down), one and one-half minutes per cycle, and continued for a total of 16 to 18 hours (average 17) daily, being stopped only for meals, baths, bedpan, muscle re-education and briefly for application of hot packs. Oscillation was stopped on the 39th day after a total period of 26 days.
On the 70th day testosterone propionate 25 mgm. i.m.
daily was begun, and this was continued for 36 days; testosterone administration was accompanied by an increase in the number of erections without nocturnal emissions and by transient acne. For 18 days during latter half of testosterone administration Progynon-B 1.66 mgm. i.m. daily was given also, accompanied by the transient appearance of tiny capillary hemangiomata over the anterior chest and upper abdomen and transient nipple soreness. Both hormones were discontinued on the 105th day, followed by a few days of fullness and tenderness of the areolae. After an interval of three months during which the patient improved to the point of beginning to stand between parallel bars (detailed below), testosterone propionate was again given, 25 mgm. i.m. daily for 36 days, beginning on the 190th day. Progynon-B, 1.66 mgm. i.m. daily, was added during the last 18 days of testosterone. Slight tenderness about the areolae and firm, flat tissue 3 by 3 cm. in area under the areolae was noted during the last 10 days of hormone administration and for approximately 10 days after both hormones were discontinued (225th day). During the last week of administration of the hormones the patient was beginning to take a few steps with long leg braces and crutches. Standard therapy and course: Hot pack therapy 3 hours daily was begun on the day after admission, was supplemented with hot tub 20 min. daily beginning on the 20th day; prone and pin-on packs were continued for 3 months. Passive motion and muscle re-education were begun on 13th day; from the 58th day muscle re-education was given in the pool and from 133rd day in gymnasium as well as pool. Because of continuing weight loss and excellent appetite, dietary intake on 124th day was raised from 2400 to 2800 calories, the protein and calcium intake remaining unchanged. The patient began sitting in chair on 130th day, began standing and taking few steps in pool on 150th day, standing in gym 172nd day. Muscle examination 6 months after onset is given in Appendix A, Table XIX . Walking a few steps with long leg braces and "walker" was begun 214th day, and with crutches as well 220th day, being very gradually increased during the eighth month.
Patient was discharged on 262nd day and thereafter received physical therapy as an out-patient. He returned to his office half-time shortly after discharge and since 1951 has been working full-time, chiefly from wheelchair. 5 (Table I) was begun on 50th day. Special procedures: The patient was placed on a Sanders oscillating bed on the 80th day after onset. The daily period on this bed averaged 14 hours (6 p.m. to 8:30 a.m.); arc of excursion was 20 degrees (2 degrees head down and 18 degrees feet down) with one complete cycle every one and one-half minutes. The patient slept well while the bed was oscillating. The same day, because of ventilatory insufficiency with diminished diaphragm excusion, the patient was placed on a rapidrocking bed, rate 16/min., total arc 24 degrees (12 degrees each side of horizontal), 7 to 8 hours daily; the head of the bed was elevated so that the patient's head did not fall below the horizontal. Both forms of oscillation were discontinued after 30 days, on the 109th day. Rapid rocking only was resumed on the 128th day at the same arc and rate but for 12 hours daily; after 114 days during which time other procedures were carried out, rapid rocking was discontinued on the 241st day. Vital capacity at this time was 2400 ml.
Testosterone propionate, 25 mgm. i.m. daily, was begun on the 158th day. After 30 days the dosage was raised to 25 mgm. b.i.d. which was given for the next 12 days. Slight puffiness of ankles occurred approximately two weeks after start of therapy, but no other clinical effects were noted. Testosterone propionate, 25 mgm. i.m. daily, was again given beginning at the 287th day for 12 days; no clinical effects were noted.
Standard therapy and course: Hot pack therapy, 6 to 8 hours daily, was resumed on 51st day and, because of extreme muscle tightness, was continued for four and one-half months, to 139th day. Muscle re-education in bed was resumed on 52nd day, from 146th day was given in pool and from 239th day in gymnasium as well as pool. The slow improvement in muscle function is indicated in the muscle examination at 6 months (Appendix A, Table XIX) .
On 206th day after onset, following immersion in pool, patient had malaise, nausea, temperature elevation to 39.2°C. and slight suppression of breath sounds at right base in posterior axillary line without evidence of infiltration by X-ray. Fifty thousand units aqueous penicillin q. 3 h. for 72 hours resulted in prompt clearing of signs. Duration of temperature elevation was 36 hours without evident effect upon excretion of metabolic constituents.
Patient began sitting in chair and standing in pool on 239th day. Patient stood in braces on ward on 271st day and was gradually able to shift weight from one leg to other while standing for 20 to 30 minutes daily. Patient was discharged on 301st day for two-week leave of absence, then readmitted to a general medical ward for continued physical therapy. Ultimate rehabilitation has been chiefly wheelchair.
8. J.W., 20-year-old housewife and mother (NYH No. 466391); onset of illness June 27, 1946, with backache, pains in legs, fatigue and fever. Onset of paralysis, chiefly involving legs, June 30, 3rd day after onset. Admitted to St. Mary's Hospital, West Palm Beach, Florida, where muscle weakness increased to involve abdomen, back, left shoulder and hand; for two weeks function of urinary bladder and intestinal tract was impaired so that catheterization and enemas were required. Hot pack therapy, 2 to 4 hours daily, and muscle re-education were given throughout patient's 11-week stay in St. Mary's Hospital. Patient began sitting in chair 9 weeks after onset.
Patient was transferred to New York State Reconstruction Hospital, West Haverstraw, N. Y., October 7, 102nd day after onset. Muscle re-education in pool was resumed and walking in pool with braces and walker was begun 4 weeks later.
Patient was transferred to New York Hospital, Metabolism Ward, January 19, 1947, 206th day (7 months) after onset. Physical examination revealed normal vital signs and rather marked muscle paralysis of lower extremities as indicated in muscle examination given in Appendix A, Table XIX. X-rays of the skeleton revealed osteoporosis of the pelvis and of the ends of the long bones. Constant dietary intake was begun on 212th day (Table I) .
Special procedures: The patient was placed on a Sanders oscillating bed on the 258th day. Arc of excursion was 2 degrees head down to 15 degrees feet down, cycle 2 minutes, 17 to 18 hours per day. Oscillation was discontinued after 42 days. The patient was comfortable and slept well on the bed.
Testosterone propionate 25 mgm. i.m. b.i.d. (total 50 mgm. daily) was given for 12 days beginning at the 321st day; no clinical effects were noted.
Standard therapy and course: Muscle re-education in gymnasium was begun on admission. Patient sat in chair one and one-half hours daily until 351st day when time sitting was increased and patient began standing and walking in long leg braces in "walker." Patient was discharged on 370th day to continue physical therapy as an out-patient.
9. R.V.K., 19-year-old female student nurse (NYH No. 460945); onset of illness July 9, 1945, with fever, muscular aching and weakness. Onset of paralysis involving all four limbs, July 10, on which day she was admitted to Willard Parker Hospital, New York City. Degree of paralysis increased and on 4th day after onset patient was placed in tank respirator in which she remained for 17 days. Additional treatment in Willard Parker Hospital included hot packs and hot tub 15 minutes daily. By 6 weeks after onset patient could move head from side to side and move left arm by crawling with fingers.
On August 21, 43rd day after onset, patient was transferred to New York State Reconstruction Hospital, West Haverstraw, New York, where hot packs were continued for an additional 5 weeks. Muscle re-education in bed and in pool was given daily with slow improvement in muscle function, initially in the left arm, later neck flexors, right arm and leg. In September, 1946, 14 months after onset, patient began sitting in chair 2 hours daily.
Patient was transferred to New York Hospital, Metabolism Ward, November 17, 1946, 496th day (17 months) after onset. Physical examination revealed normal vital signs, marked malnutrition (body weight 28.7
Kg.) and extensive muscle paralysis as indicated in muscle examination given in Appendix A, Table XIX . X-rays of the skeleton revealed osteoporosis of the pelvis and long bones, more pronounced at the ends of the latter. Intravenous pyelography revealed no evidence of urinary tract calculi. Since the patient at rare intervals had slight regurgitation into the nose, fluoroscopic examination of the esophagus was performed but was negative. Fluoroscopy of the chest revealed an elevated and fixed right diaphragm. Constant dietary intake (Table  I) was begun on 503rd day.
Special procedures: R.V.K. was placed on a Sanders oscillating bed on the 543rd day after onset. Oscillation was continued for 42 days. The excursion was 23 degrees (head down 3 degrees, feet down 20 degrees), the rate one cycle every 150 seconds (excessive vibration at more rapid rate) and the daily period eighteen and onehalf hours. During oscillation the patient slept better than previously and stated that her feet were always warm; one week after cessation of oscillation patient complained of coldness of feet.
On the 615th day testosterone propionate 25 mgm. b.i.d. (total 50 mgm. daily) was begun and was given for 18 days. Slight huskiness of the voice and a small amount of facial acne appeared 13 days after the beginning of testosterone administration.
Progynon-B, 5000 rat units, i.m. b.i.d. (total 1.66 mgm. daily) was begun on the 671st day and continued for 24 days. During the final 12 days of estrogen administration testosterone propionate, 25 mgm. i.m. b.i.d. (total 50 mgm. daily), was also given. On the final day of combined hormone administration slight huskiness of the voice was noted; this subsided in three days.
Standard therapy and course: Muscle re-education and streching in bed and in gymnasium were begun on entry. There was slight improvement in muscle function, chiefly in the left arm, during patient's 8-month stay. R.V.K. sat in chair one and one-half hours daily until last 3 weeks of her stay (719th day) when time sitting was increased gradually to 6 hours and she began standing in aluminum long leg braces 5 to 15 minutes once a day. Pa Special procedure: The patient was placed on a Sanders oscillating bed on the 24th day after onset. Arc of excursion was 18 degrees (1 degree head down and 17 feet down), and time for complete cycle one and one-half minutes; daily time period oscillating averaged 16 hours. Oscillation was discontinued on the 44th day after a total period of 21 days.
Standard therapy and course: Hot pack therapy was continued for the first two months. Passive motion and muscle re-education were begun in bed on the 17th day and from the 31st day were given in the pool. The patient began standing in the pool with water to axillae on the 35th day, began sitting in a chair 60th day, and began walking (unsupported) on the 64th day. Ventilatory capacity improved gradually and V. C. was 1000 ml. on 64th day. Patient was discharged home on the 71st day and thereafter received physical therapy as an outpatient.
